Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT). (Q37281267)
Jump to navigation
Jump to search
scientific article published on 08 August 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT). |
scientific article published on 08 August 2016 |
Statements
Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT) (English)
P Saiag
R Gutzmer
M Maio
P Murawa
B Dreno
M Ross
J Weber
A Hauschild
A Enk
L Misery
C Vanden Abeele
I Vojtek
O Peeters
V G Brichard
P Therasse
1 reference
1 reference